HomeCompareNATI vs JNJ

NATI vs JNJ: Dividend Comparison 2026

NATI yields 1.87% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NATI wins by $10.5K in total portfolio value
10 years
NATI
NATI
● Live price
1.87%
Share price
$59.99
Annual div
$1.12
5Y div CAGR
33.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,941.70
Full NATI calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — NATI vs JNJ

📍 NATI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNATIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NATI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NATI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NATI
Annual income on $10K today (after 15% tax)
$158.69/yr
After 10yr DRIP, annual income (after tax)
$5,050.45/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, NATI beats the other by $1,064.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NATI + JNJ for your $10,000?

NATI: 50%JNJ: 50%
100% JNJ50/50100% NATI
Portfolio after 10yr
$35.5K
Annual income
$5,315.55/yr
Blended yield
14.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NATI
Analyst Ratings
3
Buy
11
Hold
Consensus: Hold
Price Target
$43.33
-27.8% upside vs current
Range: $35.00 — $52.00
Altman Z
5.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NATI buys
0
JNJ buys
0
No recent congressional trades found for NATI or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNATIJNJ
Forward yield1.87%2.13%
Annual dividend / share$1.12$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.5%28%
Portfolio after 10y$40.8K$30.3K
Annual income after 10y$5,941.70$4,689.40
Total dividends collected$18.2K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$43.33$228.73

Year-by-year: NATI vs JNJ ($10,000, DRIP)

YearNATI PortfolioNATI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,949$249.24$10,592$272.30+$357.00NATI
2$12,056$340.49$11,289$357.73+$767.00NATI
3$13,368$467.76$12,123$472.89+$1.2KNATI
4$14,951$647.11$13,141$629.86+$1.8KNATI
5$16,900$902.97$14,408$846.81+$2.5KNATI
6$19,357$1,273.51$16,021$1,151.60+$3.3KNATI
7$22,532$1,819.86$18,122$1,588.22+$4.4KNATI
8$26,752$2,642.99$20,930$2,228.20+$5.8KNATI
9$32,540$3,915.20$24,792$3,191.91+$7.7KNATI
10$40,759$5,941.70$30,274$4,689.40+$10.5KNATI

NATI vs JNJ: Complete Analysis 2026

NATIStock

National Instruments Corporation provides a software-centric platform and systems to engineers and scientists worldwide. Its programming environments software includes NI LabVIEW, a graphical software platform to visualize hardware configuration, measurement data, and debugging of application; NI LabWindows/CVI, an ANSI C integrated development environment and engineering toolbox; and NI Measurement Studio, a suite of .NET tools for building engineering applications in Microsoft Visual Studio. The company's application software comprises NI TestStand that is used for automated test and measurement applications in manufacturing environment; NI VeriStand, a software environment for configuring real-time testing applications; Flexlogger for sensor configuration and data logging of mixed signals; and NI InsightCM Enterprise, a software for monitoring ancillary rotating equipment. Its operations management and analytic enterprise software include NI DIAdem, which is configuration-based technical data management, analysis, and report generation tools to mine and analyze engineering and measurement data; NI SystemLink, a systems management and data collection software that enables the mass coordination of connected devices, software deployments, and data communications throughout a distributed system; and NI Optimal Plus. The company also offers PXI hardware form factor; and NI semiconductor test systems, as well as software and hardware maintenance, and training and certification services. It serves semiconductor, transportation, aerospace, and defense industries; and government agencies. National Instruments Corporation has strategic agreements with Konrad Technologies, Inc. to develop test systems and solutions for autonomous driving software and hardware validation; and Foretellix Ltd. to enhance the safety of advanced driver-assistance systems and autonomous vehicles. The company was incorporated in 1976 and is headquartered in Austin, Texas.

Full NATI Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NATI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NATI vs SCHDNATI vs JEPINATI vs ONATI vs KONATI vs MAINNATI vs ABBVNATI vs MRKNATI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.